1. Liver Cancer Immunity
   Sumera I. Ilyas et al, 2021, Hepatology CrossRef
2. Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models
   Khanh B. Tran et al, 2022, Molecular Cancer Therapeutics CrossRef
3. The platelet-to-lymphocyte ratio as a predictor of patient outcomes in ovarian cancer: a meta-analysis
   X-M. Ma et al, 2017, Climacteric CrossRef
4. Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors
   Jiangnan Liu et al, 2024, Heliyon CrossRef
5. Safety and efficacy profile of lenvatinib in cancer therapy: a systematic review and meta-analysis
   Chenjing Zhu et al, 2016, Oncotarget CrossRef
6. Unravelling the pharmacologic opportunities and future directions for targeted therapies in gastro-intestinal cancers Part 1: GI carcinomas
   Cindy Neuzillet et al, 2017, Pharmacology & Therapeutics CrossRef
7. Immune checkpoint Inhibitor–Induced diarrhea and Colitis: Incidence and Management. A systematic review and Meta-analysis
   Dorte Lisbet Nielsen et al, 2022, Cancer Treatment Reviews CrossRef
8. Chemotherapy Maintenance
   Pashtoon Murtaza Kasi et al, 2016, The Cancer Journal CrossRef
9. Bosutinib reduces endothelial permeability and organ failure in a rat polytrauma transfusion model
   Derek J.B. Kleinveld et al, 2021, British Journal of Anaesthesia CrossRef